Published in Neuropharmacology on May 07, 2008
Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol (2009) 1.31
Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res Treat (2011) 1.30
Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clin Cancer Res (2012) 1.17
The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells. J Invest Dermatol (2010) 1.07
Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells. Oncogene (2012) 1.01
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications. Int J Biol Sci (2013) 0.96
AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). Pigment Cell Melanoma Res (2009) 0.95
Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin-like growth factor 1 receptor. Pigment Cell Melanoma Res (2014) 0.85
mGlu Receptors and Cancerous Growth. Wiley Interdiscip Rev Membr Transp Signal (2011) 0.84
Ischemia-reperfusion injury of the cochlea: pharmacological strategies for cochlear protection and implications of glutamate and reactive oxygen species. Curr Neuropharmacol (2010) 0.83
Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer. PLoS One (2014) 0.82
Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes. PLoS One (2013) 0.81
Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression. Transl Oncol (2015) 0.79
Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell lines. BMC Biotechnol (2010) 0.78
Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma. PLoS One (2012) 0.77
Effect of (S)-3,5-DHPG on microRNA expression in mouse brain. Exp Neurol (2012) 0.76
Extending the knowledge in histochemistry and cell biology. Histochem Cell Biol (2009) 0.75
Cloned glutamate receptors. Annu Rev Neurosci (1994) 10.58
Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol (1997) 10.26
Identification of cells initiating human melanomas. Nature (2008) 8.28
A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res (2005) 7.86
The metabotropic glutamate receptors: structure and functions. Neuropharmacology (1995) 5.11
Molecular diversity of glutamate receptors and implications for brain function. Science (1992) 4.90
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet (2005) 4.70
V599EB-RAF is an oncogene in melanocytes. Cancer Res (2004) 4.49
The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol (1989) 4.21
A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer (1987) 3.80
Glutamate release promotes growth of malignant gliomas. Nat Med (2001) 3.67
Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr (2000) 3.19
Sequence and expression of a metabotropic glutamate receptor. Nature (1991) 2.97
The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron (1993) 2.67
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet (2003) 2.67
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev (1997) 2.47
Glutamate in plants: metabolism, regulation, and signalling. J Exp Bot (2007) 2.40
Increased expression of stem cell markers in malignant melanoma. Mod Pathol (2006) 2.39
A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature (1987) 2.15
Glutamate stimulates inositol phosphate formation in striatal neurones. Nature (1985) 2.02
Glutamate antagonists limit tumor growth. Proc Natl Acad Sci U S A (2001) 1.88
Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res (2007) 1.82
A mouse model system to genetically dissect the molecular mechanisms regulating tumorigenesis. Clin Cancer Res (2006) 1.74
Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol Pharmacol (2003) 1.72
Tumour progression and the nature of cancer. Br J Cancer (1991) 1.69
Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain. Science (1991) 1.62
The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J Neurosci (1986) 1.61
Malignant melanoma in transgenic mice. Proc Natl Acad Sci U S A (1991) 1.58
Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol (2006) 1.48
Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci (2003) 1.44
Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. Pigment Cell Melanoma Res (2008) 1.37
Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: developmental changes and interaction with alpha 1-adrenoceptors. Proc Natl Acad Sci U S A (1986) 1.34
Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J Cell Biol (1989) 1.32
Positive and negative coupling of the metabotropic glutamate receptors to a G protein-activated K+ channel, GIRK, in Xenopus oocytes. J Gen Physiol (1997) 1.22
Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo. Neuro Oncol (2005) 1.09
Glutamate receptors on human melanocytes regulate the expression of MiTF. Pigment Cell Res (2006) 1.08
Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J (2006) 1.07
Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. J Neurosci (2006) 1.06
Get receptive to metabotropic glutamate receptors. Curr Opin Neurobiol (1995) 1.06
Glutamate: an amino acid of particular distinction. J Nutr (2000) 1.05
Evidence for a novel glutamate-mediated signaling pathway in keratinocytes. J Invest Dermatol (1999) 1.04
Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells. J Neurochem (2003) 1.03
Astrocyte glutamate receptor activation promotes inositol phospholipid turnover and calcium flux. Neurosci Lett (1986) 1.02
Commitment of mouse fibroblasts to adipocyte differentiation by DNA transfection. Science (1989) 1.01
Metabotropic glutamate receptors in stem/progenitor cells. Neuropharmacology (2007) 1.01
Agonist-induced internalization of the metabotropic glutamate receptor 1a is arrestin- and dynamin-dependent. J Neurochem (2001) 0.99
Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin Cancer Res (2005) 0.98
Cloning of novel splice variants of mouse mGluR1. Brain Res Mol Brain Res (1999) 0.96
Insulin secretion is controlled by mGlu5 metabotropic glutamate receptors. Mol Pharmacol (2006) 0.96
Development of heritable melanoma in transgenic mice. J Invest Dermatol (1998) 0.96
Spontaneous melanocytosis in transgenic mice. J Invest Dermatol (1996) 0.96
Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma. Oncol Rep (2007) 0.95
Induction of melanoma in TPras transgenic mice. Carcinogenesis (1999) 0.95
Metabotropic glutamate receptors are involved in amygdaloid plasticity. Eur J Neurosci (2002) 0.95
Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes. J Cell Physiol (2000) 0.92
Expression of metabotropic glutamate receptors in murine thymocytes and thymic stromal cells. J Neuroimmunol (2000) 0.91
Regulation of the mGluR5, EAAT1 and GS expression by glucocorticoids in MG-63 osteoblast-like osteosarcoma cells. J Musculoskelet Neuronal Interact (2007) 0.91
The glutamatergic system outside the CNS and in cancer biology. Expert Opin Investig Drugs (2005) 0.91
Localization and function of group III metabotropic glutamate receptors in rat pancreatic islets. Am J Physiol Endocrinol Metab (2002) 0.91
Selective blockade of mGlu5 metabotropic glutamate receptors protects rat hepatocytes against hypoxic damage. Hepatology (2000) 0.89
Dependence of long-term depression on postsynaptic metabotropic glutamate receptors in visual cortex. Proc Natl Acad Sci U S A (1993) 0.88
Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes. Neuropharmacology (2005) 0.87
Effects of coexpression with Homer isoforms on the function of metabotropic glutamate receptor 1alpha. Mol Cell Neurosci (2003) 0.85
Agonist-independent internalization of metabotropic glutamate receptor 1a is arrestin- and clathrin-dependent and is suppressed by receptor inverse agonists. J Neurochem (2004) 0.84
Acute mechanical hyperalgesia is produced by coactivation of AMPA and metabotropic glutamate receptors. Neuroreport (1993) 0.83
Development of early melanocytic lesions in transgenic mice predisposed to melanoma. Pigment Cell Res (2000) 0.82
Immunochemical localization of the metabotropic glutamate receptors in the rat heart. Brain Res Bull (1999) 0.82
Characterization of metabotropic glutamate receptors in rat C6 glioma cells. Eur J Pharmacol (1997) 0.81
Excitatory amino acid-induced slow biphasic responses of free intracellular calcium in human neuroblastoma cells. FEBS Lett (1993) 0.80
Microinjections of the metabotropic glutamate receptor agonist, trans-(+/-)-1-amino-cyclopentane-1,3-dicarboxylate (trans-ACPD) into the amygdala increase the acoustic startle response of rats. Brain Res (1993) 0.78
Metabotropic glutamate receptor in C6BU-1 glioma cell has NMDA receptor-ion channel complex-like properties and interacts with serotonin2 receptor-stimulated signal transduction. J Neurochem (1994) 0.76
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet (2003) 2.67
Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res (2007) 1.82
Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon. Cell Signal (2005) 1.50
Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. Pigment Cell Melanoma Res (2008) 1.37
Cloning and characterization of a novel gene, SHPRH, encoding a conserved putative protein with SNF2/helicase and PHD-finger domains from the 6q24 region. Genomics (2003) 1.25
A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma. Clin Cancer Res (2009) 1.24
Progressive appearance of pigmentation in amelanotic melanoma lesions. Pigment Cell Res (2002) 1.08
Identification and characterization of mouse Rab32 by mRNA and protein expression analysis. Biochim Biophys Acta (2003) 1.07
Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profiling. Bioorg Med Chem (2012) 1.02
Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies. Clin Cancer Res (2011) 1.01
Exchange protein directly activated by cyclic AMP increases melanoma cell migration by a Ca2+-dependent mechanism. Cancer Res (2010) 0.98
G-protein-coupled receptors and melanoma. Pigment Cell Melanoma Res (2008) 0.97
Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Res (2007) 0.97
AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). Pigment Cell Melanoma Res (2009) 0.95
Glutamatergic signaling in cellular transformation. Pigment Cell Melanoma Res (2012) 0.94
Albumin nanoshell encapsulation of near-infrared-excitable rare-Earth nanoparticles enhances biocompatibility and enables targeted cell imaging. Small (2010) 0.91
Functional effects of GRM1 suppression in human melanoma cells. Mol Cancer Res (2012) 0.91
Genetics of melanoma. Front Genet (2013) 0.91
Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor. Int J Oncol (2005) 0.90
Induction of CYP1A1 and CYP1A2 expressions by prototypic and atypical inducers in the human lung. Cancer Lett (2002) 0.88
Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes. Neuropharmacology (2005) 0.87
Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo. Clin Cancer Res (2011) 0.87
Epac1 promotes melanoma metastasis via modification of heparan sulfate. Pigment Cell Melanoma Res (2011) 0.87
Anatomical distribution analysis reveals lack of Langerin+ dermal dendritic cells in footpads and tail of C57BL/6 mice. Exp Dermatol (2014) 0.85
Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development. J Mol Med (Berl) (2004) 0.85
Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin-like growth factor 1 receptor. Pigment Cell Melanoma Res (2014) 0.85
Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases. Exp Dermatol (2012) 0.84
mGlu Receptors and Cancerous Growth. Wiley Interdiscip Rev Membr Transp Signal (2011) 0.84
Loss of heterozygosity and internal tandem duplication mutations of the CBP gene are frequent events in human esophageal squamous cell carcinoma. Clin Cancer Res (2004) 0.83
Multifunctional albumin nanoparticles as combination drug carriers for intra-tumoral chemotherapy. Adv Healthc Mater (2013) 0.82
Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes. PLoS One (2013) 0.81
U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo. Mol Ther Nucleic Acids (2013) 0.81
Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression. Cancer Res (2014) 0.80
Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling. Pigment Cell Melanoma Res (2014) 0.80
Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells. Breast Cancer Res Treat (2015) 0.80
Gβγ subunits inhibit Epac-induced melanoma cell migration. BMC Cancer (2011) 0.80
From existing therapies to novel targets: a current view on melanoma. Front Biosci (2006) 0.79
Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma. Cancer Immunol Immunother (2012) 0.78
Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy. Pharm Res (2014) 0.78
Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells. Pigment Cell Melanoma Res (2014) 0.77
Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells. Pigment Cell Melanoma Res (2014) 0.77
The current management of brain metastasis in melanoma: a focus on riluzole. Expert Rev Neurother (2015) 0.76
Regulation of mGluR1 expression in human melanocytes and melanoma cells. Biochim Biophys Acta (2012) 0.76
Glutamate receptors: emerging players in melanomagenesis. Pigment Cell Melanoma Res (2011) 0.75